Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection

Details for Australian Patent Application No. 2006299426 (hide)

Owner Scynexis, Inc.

Inventors Houck, David Renwick

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006299426

PCT Pub. Number WO2007/041632

Priority 60/722,679 30.09.05 US; 60/787,549 29.03.06 US

Filing date 2 October 2006

Wipo publication date 12 April 2007

Acceptance publication date 26 July 2012

International Classifications

A61K 38/13 Medicinal preparations containing peptides

A61K 38/21 Medicinal preparations containing peptides - Interferons

A61P 31/14 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/041632 Priority application(s): WO2007/041632

26 July 2012 Application Accepted

  Published as AU-B-2006299426

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006299428-Pyrimidine amide compounds as PGDS inhibitors

2006299424-Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties